Neogen (NEOG) Capital Expenditures Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neogen | 1.94 Bn | 1.78 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 6.98% |
| Nov 30, 2025 | 11.26% |
| Aug 31, 2025 | 41.39% |
| May 31, 2025 | 15.80% |
| Feb 28, 2025 | 56.41% |
| Nov 30, 2024 | 22.04% |
| Aug 31, 2024 | 42.81% |
| May 31, 2024 | 54.18% |
| Feb 29, 2024 | 44.17% |
| Nov 30, 2023 | 38.44% |
| Aug 31, 2023 | 74.04% |
| May 31, 2023 | 40.56% |
| Feb 28, 2023 | 20.81% |
| Nov 30, 2022 | 15.10% |
| Aug 31, 2022 | 24.10% |
| May 31, 2022 | 51.40% |
| Feb 28, 2022 | -0.32% |
| Nov 30, 2021 | 7.13% |
| Aug 31, 2021 | -17.78% |
| May 31, 2021 | 18.92% |
| Feb 28, 2021 | 20.04% |
| Nov 30, 2020 | 6.51% |
| Aug 31, 2020 | 8.53% |
| May 31, 2020 | 22.89% |
| Feb 29, 2020 | 10.28% |
| Nov 30, 2019 | 23.63% |
| Aug 31, 2019 | 20.84% |
| May 31, 2019 | -7.88% |
| Feb 28, 2019 | 12.55% |
| Nov 30, 2018 | 14.41% |
| Aug 31, 2018 | -1.24% |
| May 31, 2018 | 19.27% |
| Feb 28, 2018 | 10.33% |
| Nov 30, 2017 | 32.88% |
| Aug 31, 2017 | 18.08% |
| May 31, 2017 | -0.21% |
| Feb 28, 2017 | 28.60% |
| Nov 30, 2016 | 6.17% |
| Aug 31, 2016 | -12.78% |
| May 31, 2016 | 4.72% |
| Feb 29, 2016 | 11.53% |
| Nov 30, 2015 | 21.98% |
| Aug 31, 2015 | 12.38% |